NATURE’S SUNSHINE PRODUCTS, INC. Operating Leases, Rent Expense
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Operating Leases, Rent Expense of $6.70 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-03-10
- NATURE’S SUNSHINE PRODUCTS, INC. operating leases, rent expense for fiscal 2019 was $6.70M, a 21.18% decline from fiscal 2018.
- NATURE’S SUNSHINE PRODUCTS, INC. operating leases, rent expense for fiscal 2018 was $8.50M.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2019-12-31 | $6.70M 10-K · filed 2021-03-10 |
| 2018-12-31 | $8.50M 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |